Imiquimod-induced bullous pemphigoid: A case report

A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol o...

Full description

Bibliographic Details
Main Authors: Heidi Oi-Yee Li, Michael Aw, Steven J Glassman
Format: Article
Language:English
Published: SAGE Publishing 2023-03-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X231164222
_version_ 1797854958784086016
author Heidi Oi-Yee Li
Michael Aw
Steven J Glassman
author_facet Heidi Oi-Yee Li
Michael Aw
Steven J Glassman
author_sort Heidi Oi-Yee Li
collection DOAJ
description A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol ointment, prednisone and methotrexate, with eventual disease control. He had a severe disease course. Bullous pemphigoid is usually idiopathic, but can be induced by skin trauma, as well as by several medications; this is the first report of imiquimod as a trigger. Imiquimod is a toll-like receptor 7 agonist that induces cellular apoptosis and recruits pro-inflammatory cytokines including tumour necrosis factor-alpha and interferon-alpha, which have been implicated in autoimmunity. This case highlights an unusual but severe adverse effect from topical imiquimod.
first_indexed 2024-04-09T20:15:48Z
format Article
id doaj.art-cfb77cd1662047fbbc076fd3e75443b8
institution Directory Open Access Journal
issn 2050-313X
language English
last_indexed 2024-04-09T20:15:48Z
publishDate 2023-03-01
publisher SAGE Publishing
record_format Article
series SAGE Open Medical Case Reports
spelling doaj.art-cfb77cd1662047fbbc076fd3e75443b82023-03-31T10:05:43ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2023-03-011110.1177/2050313X231164222Imiquimod-induced bullous pemphigoid: A case reportHeidi Oi-Yee Li0Michael Aw1Steven J Glassman2Faculty of Medicine, University of Ottawa, Ottawa, ON, CanadaFaculty of Medicine, University of Ottawa, Ottawa, ON, CanadaDivision of Dermatology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, CanadaA 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol ointment, prednisone and methotrexate, with eventual disease control. He had a severe disease course. Bullous pemphigoid is usually idiopathic, but can be induced by skin trauma, as well as by several medications; this is the first report of imiquimod as a trigger. Imiquimod is a toll-like receptor 7 agonist that induces cellular apoptosis and recruits pro-inflammatory cytokines including tumour necrosis factor-alpha and interferon-alpha, which have been implicated in autoimmunity. This case highlights an unusual but severe adverse effect from topical imiquimod.https://doi.org/10.1177/2050313X231164222
spellingShingle Heidi Oi-Yee Li
Michael Aw
Steven J Glassman
Imiquimod-induced bullous pemphigoid: A case report
SAGE Open Medical Case Reports
title Imiquimod-induced bullous pemphigoid: A case report
title_full Imiquimod-induced bullous pemphigoid: A case report
title_fullStr Imiquimod-induced bullous pemphigoid: A case report
title_full_unstemmed Imiquimod-induced bullous pemphigoid: A case report
title_short Imiquimod-induced bullous pemphigoid: A case report
title_sort imiquimod induced bullous pemphigoid a case report
url https://doi.org/10.1177/2050313X231164222
work_keys_str_mv AT heidioiyeeli imiquimodinducedbullouspemphigoidacasereport
AT michaelaw imiquimodinducedbullouspemphigoidacasereport
AT stevenjglassman imiquimodinducedbullouspemphigoidacasereport